Read + Share
Song Y, Li J, Zhou K, Ke X, et al. Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with
relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2024 Apr 1:1-6. doi: 10.1080/10428194.2024.2310141.
PMID: 38557285
|
 |
|
Song Y, Li J, Zhou K, Ke X, et al. Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with
relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2024 Apr 1:1-6. doi: 10.1080/10428194.2024.2310141.
PMID: 38557285
|
|
|
|